2
Clinical Trials associated with T-4090Efficacy and Safety Assessment of T4090 Ophthalmic Solution (preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (preserved Netarsudil 0.02%) in Patients with Open-angle Glaucoma or Ocular Hypertension
The main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 (Kinezodianone R HCl 0.2% and 0.3%) ophthalmic solution with Rhopressa® ophthalmic solution
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
The study purpose is to evaluate the safety of T4090.
100 Clinical Results associated with T-4090
100 Translational Medicine associated with T-4090
100 Patents (Medical) associated with T-4090
100 Deals associated with T-4090